A Phase I, Open Label, Multicenter Study Evaluating the Safety and Efficacy of Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma
Latest Information Update: 26 Feb 2025
At a glance
- Drugs Antineoplastics (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
- Sponsors GRIT Biotechnology
- 19 Jul 2024 New trial record